Company attributes
Location
B2X
CEO
Legal Name
Decipher Biosciences, Inc
Legal classification
Date Incorporated
2018
Number of Employees (Ranges)
11 – 50
Email Address
managedcare@decipherbio.com
partner@decipherbio.com
cs@decipherbio.com
Phone Number
+18887921601
Full Address
1120 Hamilton Street, Unit 201 Vancouver, BC V6B 2S2 CANADA0
737N 5th Street Suite 600 Richmond, VA 232190
6925 LUSK BLVD, SUITE 200 SAN DIEGO CA 92121 United States0
12357-A Riata Trace Parkway Building 5, Suite 100 Austin, TX 787270
163 Avenue de Luminy 13288 Marseille Cedex 9 FRANCE0
6000 Shoreline Court Suite 300 South San Francisco, CA 940800
CIK Number
Founded Date
2018
Total Funding Amount (USD)
98,827,750
Latest Funding Round Date
April 2019
Former CEO
Latest Funding Type
Patents Assigned (Count)
3
Country
Headquarters
Other attributes
Company Operating Status
Active
Decipher Biosciences is focused on utilizing genomic information to transform and improve cancer patient care by delivering accurate tests for determining the true nature of prostate and bladder cancers and enabling each patient to have a treatment plan based on the unique biology of their tumor.
Timeline
No Timeline data yet.
Funding Rounds
Products
Acquisitions
SBIR/STTR Awards
Patents
Further Resources
No Further Resources data yet.
